Background: the effect of hospitalisation in emergency department-based short-stay units (SSUs) has not been studied in older patients. We compared SSU hospitalisation with standard care at an Internal Medicine Department (IMD) in acutely admitted older internal medicine patients. Methods: pragmatic randomised clinical trial. We randomly assigned patients aged 75 years or older, acutely admitted for an internal medicine disease and assessed to be suitable for SSU hospitalisation to SSU hospitalisation or IMD hospitalisation. SSU hospitalisation was provided by a pragmatic 'fast-track' principle. The primary outcome was 90-day mortality. Secondary outcomes included adverse events, change in Lawton Instrumental Activities of Daily Living (IADL) score within 90 days from admission, in-hospital length of stay and unplanned readmissions within 30 days after discharge. Results: between January 2015 and October 2016, 430 participants were randomised (median age 84 years in both groups). Ninety-day mortality was 22(11%) in the SSU group and 32(15%) in the IMD group (odds ratio (OR) 0.66; 95% confidence interval (CI) 0.37-1.18; P = 0.16). When comparing the SSU group to the IMD group, 16(8%) vs. 45(21%) experienced at least one adverse event (OR 0.31; 95% CI 0.17-0.56; P < 0.001); 6(3%) vs. 35(20%) experienced a reduction in IADL score within 90 days from admission (P < 0.001); median in-hospital length of stay was 73 h [interquartile range, vs. 100 h [IQR 47-169], (P < 0.001), and 26(13%) vs. 58(29%) were readmitted (OR 0.37; 95% CI 0.22-0.61; P < 0.001). Conclusions: mortality at 90 days after admission was not significantly lower in the SSU group, but SSU hospitalisation was associated with a lower risk of adverse events, less functional decline, fewer readmissions and shorter hospital stay. Trial registration: NCT02395718
Introduction
An increasing number of emergency department (ED)-based short-stay units (SSUs) are being implemented to provide brief hospital stays for selected patients [1] . SSUs accommodate acutely admitted patients who need either diagnostic tests, observation or short-term treatment [2] . The majority of patients admitted to hospital are older adults who display symptoms of acute illness differently than younger adults and SSU hospitalisation may not be optimal in this vulnerable patient group [3] . On the other hand, a brief and focused hospital stay may be preferable for some older patients, because they are at high risk of experiencing functional decline and adverse events [4] . The aim of this trial was to evaluate the outcomes of ED-based SSU hospitalisation compared with Internal Medicine Department (IMD) hospitalisation in patients aged 75 years or older acutely admitted for an internal medicine disease.
The primary outcome was 90-day mortality. We hypothesised that hospitalisation in the SSU compared to the IMD would be associated with a lower 90-day mortality.
Methods Trial design and setting
We conducted a pragmatic, single-centre, parallel, randomised clinical trial at Holbaek Hospital, Denmark, a secondary referral teaching hospital with a catchment population of approximately 270,000. Acute healthcare in Denmark is provided by tax-financed public hospitals. The trial (clinicaltrials. gov identifier: NCT02395718) was approved by the Danish Data Protection Agency (Reg-106-2014) and the Regional Ethics Committee of Region Zealand, Denmark (SJ-418). The trial protocol was published [5] . Informed consent was obtained from all participants. Participants were randomly assigned 1:1 to hospitalisation in an ED-based SSU or standard care, i.e. IMD hospitalisation, according to a computer-generated randomisation sequence using blocks of variable size. We used a centralised web-based randomisation programme 'Open Randomise' provided by Odense Patient data Explorative Network, Odense University Hospital, Denmark [6] . It was impossible to blind patients and clinicians to the treatment allocation. All pre-planned analyses and interpretations were performed before breaking of the randomisation code, but we included an evaluation of healthcare utilisation post hoc.
Participants
We screened older patients, who were acutely referred to the ED for a medical problem and assessed by an ED physician to be suitable for SSU hospitalisation. Inclusion criteria were age 75 years or older, need of admission due to an internal medicine disease and green-tag triage in the ED. Triage was performed using The Danish Emergency Process Triage (DEPT) model [7] . Similar to triage tools such as the Manchester Triage System, DEPT assigns patients to five specific acuity categories based on vital signs and complaint algorithms. Green-tag triage is assigned to a patient with a less urgent need for assessment (assessment within 180 min of arrival).
Please see Appendix 1 in the Supplementary data on the journal website for exclusion criteria.
Intervention and comparison
The SSU was a multipurpose unit accommodating patients with no immediate life-threatening conditions, who were capable of walking from the bed to the bathroom without assistance and were perceived to be dischargeable within 72 h according to the physician evaluating the patient in the ED. The SSU was linked to the ED; it had eight 2-bed patient rooms and one room with six chairs for day patients. ED staff rotated between working in the ED and the SSU with exception of a few staff members who were dedicated to the SSU. The Chief physician was an internal medicine specialist.
After initial ED assessment, trial participants were transferred to the SSU to receive further diagnostic tests, observation or treatment. A key concept of the SSU was ongoing treatment and diagnostic tests were applied on a fast-track basis. Discharge planning was initiated immediately after admission. Diagnostic tests were performed on the same terms as in the ED, including point-of-care (POCT) ultrasonography, acute blood samples analysed in the ED laboratory and simple X-rays in the ED X-ray room. More advanced diagnostic examinations such as CT or MRI scans were performed at the Department of Radiology. Patients were encouraged to mobilise without assistance during the stay, which usually included getting minimal help to basic self-care activities such as bathing or walking around in the department. Physical therapists were available upon request. The comparison group received care in the IMD as usual. Contrary to the SSU, patients treated in the IMD wards did not have access to POCT ultrasound or X-rays, satellite laboratory or fast-track diagnostics at the Radiology Department unless they developed clinical deterioration. The physicians in the ED were located next to the SSU. In contrast, the internal medicine physicians on call had a wider geographical area and a higher number of patients per physician to cover during the evening and night shifts. Please see Appendix 1 in the Supplementary data on the journal website for additional description of the SSU and IMD setups.
Outcomes
The primary outcome was mortality at 90 days after admission. Secondary outcomes were mortality rate from patient inclusion to trial conclusion, in-hospital mortality, adverse events during hospitalisation, change in Lawton Instrumental Activities of Daily Living (IADL) score [8] within 90 days from admission (change in either direction), in-hospital length of stay, unplanned readmission within 30 days after discharge, relocation to a living facility with higher level of care within 90 days from admission and transfer to another treatment facility during hospitalisation.
Measurements
Mortality was retrieved from the Danish Civil Registration Registry [9] . Please see Appendix 1 in the Supplementary data on the journal website for a description of measurements of baseline characteristics, healthcare utilisation and outcomes.
Sample size
A cohort study of hospitalised octogenarians in Denmark reported a 90-day mortality rate of 20% [10] . We performed an audit that retrospectively assessed mortality in internal medicine patients aged ≥75 years with green-tag triage upon arrival admitted to hospitalisation at Holbaek Hospital; 90-day all-cause mortality was 5% vs.17% in patients admitted to the SSU vs. the IMD (unpublished).
Short-stay unit hospitalisation in older patients
We calculated that we would need to enrol 400 patients for the trial to have 90% power to detect a 10% absolute reduction in 90-day mortality at a two-sided alpha level of 0.05, assuming a 15% 90-day mortality in IMD group vs. 5% in the SSU group. Because we anticipated some dropouts, we chose to include a total of 430 patients, 215 in each group.
Statistical analysis
We performed a modified intention to treat analysis where we included all randomised patients except for those who violated the trial eligibility criteria (i.e. withdrew consent, were included twice in trial). Dichotomous data were presented as proportions, and differences between groups were calculated by logistic regression and presented as odds ratios (ORs) with 95% confidence intervals (95% CIs). Continuous outcome data were presented as median and interquartile range (IQR), and Mann-Whitney U-test was used for statistical comparison. Time from inclusion to tests or treatments were also presented by mean and standard deviation, and mean difference between groups with 95% CIs. We computed time from trial inclusion to death and calculated mortality rates. Differences between groups were calculated by Cox regression and presented as hazard ratio (HR) with 95% CIs. Kaplan-Meier survival curves were created. Very few data were missing and we did not impute missing data. All analyses were performed using STATA version 13. A two-sided P value of less than 0.05 was considered to indicate statistical significance. A scheduled interim analysis of 90-day mortality was conducted by an independent Data Monitoring Committee (DMC) after half of the trial patients were included. The DMC advised the Steering Committee to continue the trial.
Results

Trial population
The trial was conducted from 5 January 2015 to 7 October 2016. We screened 558 patients to include 430 patients in the trial, 215 in each group. In total, 12 patients (3%) were excluded from the analyses before breaking the randomisation code. Nine patients violated the trial eligibility criteria and three patients withdrew consent. Four-hundred and eighteen patients were analysed including three patients who did not receive the intended treatment defined by allocation, two in SSU group and one in the IMD group. Please see Appendix 2 in the Supplementary data on the journal website for trial profile. The groups had similar baseline characteristics, Table 1 . Healthcare utilisation is presented in Table 2 together with outcomes.
Outcomes
The primary outcome, 90-day mortality, occurred in 22 patients (10.6%) allocated to the SSU group and in 32 patients (15.2%) allocated to the IMD group (OR 0.66; 95% CI 0.37-1.18; P = 0.16). The absolute risk difference was 4.7% (95% CI −1.7-11.1%; P = 0.16). The 418 patients were observed for a total of 120,424 days (median 288 days, range 90-641 days). At the conclusion of the trial, a total of 42 patients (20%) in the SSU group and 55 patients (26%) in the IMD group had died, (HR 0.74; 95% CI 0.50-1.11; P = 0.15, Fig. 1 ).
Of the patients alive after 90 days following admission, 10 patients (5.4%) in the SSU group and 13 patients (7.3%) in the IMD group did not respond to repeated phone calls. Six patients (3.2%) in the SSU group and 35 patients (19.7%) in the IMD group experienced a reduction in IADL score within 90 days from admission. Twenty-six patients (12.9% of those discharged alive) in the SSU group and 58 patients (28.9% of those discharged alive) in the IMD group had an unplanned readmission within 30 days (OR 0.37; 95% CI 0.22-0.61; P < 0.001). Secondary outcomes are presented in Table 2 .
Discussion
In acutely admitted older patients, mortality at 90 days after admission was not significantly lower in patients randomised to treatment in an ED-based SSU (11%) compared to standard care at an IMD (15%). SSU hospitalisation was associated with significantly lower risk of adverse events, functional decline, unplanned readmissions, and hospital stay was shorter. The time to chest X-ray, CT scans, POCT ultrasound and physiotherapy was significantly shorter in the SSU group. Tests and treatments were not more frequently used in the SSU group.
This trial had several strengths: the randomised design minimised the risk of uneven allocation of unknown confounders. We used a hard endpoint, mortality, as the primary outcome to ensure scientific rigour. Obtaining mortality data from the CRS and electronic patient charts minimised the risk of information bias and kept missing values to a minimum. The proportion of patients unavailable for telephone interview was low for both groups. The pragmatic design of the trial reflected everyday practice; we did not implement or invent new strategies to conduct the trial. All data analyses were performed blinded for allocation labels. The trial also had limitations. A primary concern was our inability to blind involved healthcare personnel and patients. Hawthorne effect could potentially have affected outcomes [11] . We did not assess the complexity and severity of other hospitalised patients, which might have drained staff resources and thereby affected patient care in the SSU and the IMD. We planned to make intention to treat analyses; however, we chose to exclude 12 patients due to randomisation errors and withdrawals. Finally, we based the sample size calculation on estimates from retrospective audits, which suggested a very large difference in mortality. The observed absolute risk reduction of 4.7% in mortality was not statistically significant, however, the trial was underpowered to detect such a small but clinically relevant difference.
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We have no knowledge of other trials specifically randomising older patients to hospitalisation in an ED-based SSU. Trials have investigated the effectiveness of providing standardised diagnostic or interventional protocols in EDbased SSUs for specific conditions, e.g. acute exacerbation of chest pain [12] [13] [14] or syncope [15, 16] ; very few patients over 75 years have been included in these trials. In a large observational study, Russell et al. concluded that a medical SSU was not more efficient than a traditional model of hospitalisation [17] . In 23,790 internal medicine patients (mean age 67.5), they found SSU hospitalisation to be safe and the proportion of readmissions to be low (9.4%). But length of stay was not shorter than traditional care when taking factors such as age and complexity of illness into account. The 29% readmission rate in our IMD group was comparable to the 33% found in other studies [18] and significantly higher than in our SSU group.
Our trial was a pragmatic trial investigating a system approach. We hypothesise that the cluster of fast-track principles applied in the SSU may explain the difference between outcomes; e.g. shorter time to tests, early initiation of physiotherapy, encouragement to mobilise with minimal assistance and discharge planning initiated upon arrival. An implicit aim of fast-track care is to reduce time spent in hospital. Similar to previous trials [12-16, 19, 20] , we found that SSU hospitalisation was associated with reduced length of stay in comparison with standard care. Hospitalisation is associated with a risk of adverse events and we found fewer adverse events in the SSU group. Occurrence of adverse events could have been shifted to the outpatient setting. However, we found no indications that the SSU patients experienced a higher number of adverse events after discharge, which would likely have led to a higher number of Short-stay unit hospitalisation in older patients readmissions or deaths. Further, bed rest is known to be a major hazard to older patients [21] . Reductions in ADL scores can be detected already at the second day of hospitalisation, and patients who stay in bed are at higher risk of adverse events [22, 23] . Our results indicated that patients randomised to the SSU had a lower risk of experiencing loss in IADL score. That could be related to less loss of muscle mass and functional capacity. Many SSUs use a maximum length of stay limit of 24 or 48 h [2, 24, 25] . Length of stay in both of our study groups was longer than 48 h. Whether older patients should be treated in SSUs that strictly enforce length of stay limits of 24 or 48 h can be questioned. The fast-track principles applied in the SSU rely on immediate access to physician evaluations 24/7, which is possible in an ED-based setup. Hence, the different physician staffing per patient in the SSU and the IMD during the evening and night might also have contributed to differences in outcomes.
Our results suggest that SSU hospitalisation has costsparing properties. We found shorter hospital stays, fewer readmissions, fewer patients with functional decline and lower use of resources in the SSU group. It is uncertain whether the lower costs are counterbalanced by an increased use of resources after discharge.
The American College of Emergency Physicians (ACEP) recommends implementation of ED-based SSUs [26] . The results of our trial support that larger trials are needed to increase the certainty of findings and multicentre trials are needed to test different hospital settings. ACEP has appointed strict treatment protocols and well-defined admission criteria to be important traits of an effective SSU setup. Future trials should explore differences between the effectiveness of using pragmatic fast-track principles as compared to protocolled care. Our trial showed that most tests and treatments were initiated within the first 24 h of hospitalisation in the SSU, however, an even more aggressive fast-track process eliminating time to any diagnostic test would be interesting to explore.
The pragmatic SSU setup represents a simple approach that does not rely on extra time-consuming assessments in the ED, but it relies on subjective judgments of the medical staff. Finally, trials should investigate whether the same principles applied in the traditional care setting will lead to similar improved outcomes, many of the components of the SSU intervention could be applied in other settings.
Conclusion
SSU hospitalisation may be preferable in acutely admitted older internal medicine patients.
Key points
• We found no difference in mortality between SSU hospitalisation and usual care.
• SSU hospitalisation was associated with lower risk of adverse events and less functional decline.
• SSU hospitalisation was associated with fewer readmissions and shorter hospital stays.
• SSU hospitalisation seems to be a viable alternative to usual care in older patients.
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